Efficacy of Local Powder Prophylactics
Primary Purpose
Infection
Status
Unknown status
Phase
Not Applicable
Locations
India
Study Type
Interventional
Intervention
Vancomycin
Vancomycin and Gentamycin
Cefuroxime
Sponsored by

About this trial
This is an interventional prevention trial for Infection focused on measuring Vancomycin, Gentamycin, Local Powder Antibiotic's Efficacy in Controlling Post Surgical Infection
Eligibility Criteria
Inclusion Criteria:
- All joint replacement patients
- All non infected spine patients
- Hemiarthroplasty, All upper limb plating of closed fractures
Exclusion Criteria:
- Open injuries in trauma
- Revision joint replacement surgeries
- Patients with suspicion of existing infection
Sites / Locations
- Ganga Hospital, Orthopaedics DepartmentRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Active Comparator
Active Comparator
Active Comparator
Arm Label
Vancomycin
Vancomycin and Gentamycin
Intravenous Antibiotic
Arm Description
Outcomes
Primary Outcome Measures
Infection percent after surgery
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01372371
Brief Title
Efficacy of Local Powder Prophylactics
Official Title
Effects of Applying Powdered Prophylactics Verses Intravenous Antibiotics Only on Post-operative Infection Rate
Study Type
Interventional
2. Study Status
Record Verification Date
June 2011
Overall Recruitment Status
Unknown status
Study Start Date
June 2011 (undefined)
Primary Completion Date
June 2012 (Anticipated)
Study Completion Date
June 2013 (Anticipated)
3. Sponsor/Collaborators
Name of the Sponsor
Ganga Hospital
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Hypothesis: Directly applying antibiotic powder onto the site of surgery along with perioperative intravenous antibiotics, before closing the wound, is more effective than intravenously applied perioperative antibiotics alone in controlling post-operative wound infection. The investigators also think powders that control both gram positive and gram negative bacteria are more beneficial.
Detailed Description
Subjects will be divided into three groups based on the procedure used for the application of antibiotics
No local antibiotics (control group): In this group, individuals will be subjected to peri-operative intravenous* antibiotics only
Gram positive antibiotic: In this group, gram positive (powdered vancomycin)+ will be applied to the site of surgery, before closure of the wound, along with peri-operative intravenous antibiotics*
Gram positive and gram negative: In this group, gram positive (powdered vancomycin) will be instilled on the site of surgery, before closing the wound, and gram negative antibiotic (gentamycin mixed with bone cement)+ will be used, along with peri-operative intravenous antibiotics* (only in cases of implant fixation).
Intravenous antibiotic dosage: 1 pre-operative dose of Cefuroxime 1.5 gm and 2 post-operative doses of Cefuroxime 750 mg.
Vancomycin and Gentamycin dosage: 500 mg of vancomycin powder will be used and in group 'c' gentamycin mixed with bone cement will be used along with vancomycin powder.
Sample size: Based on, finding at least 4% difference between the proportions of infections found in control (generally 5%, 4% in case of joint replacement) and case groups (1%) (proportions were assumed from literature and our institute records), a sample size of minimum 285 in each group (424 for joint replacement cases) will be considered for the observation to be significant at an alpha level of 0.05. This will give the study a minimum power of 80%.
Spine cases: Control = 143, Gram-P = 143; Trauma cases: Control = 143, Gram-P = 143; Joint replacement cases: Control = 424, Gram-P = 424, Gram-P+Gram-N = 424; Total = 1844; Where Control - Cases with intravenous antibiotic dose; Gram-P - Cases with intravenous antibiotic + local antibiotic (Vancomycin, acts against gram positive bacteria); Gram-N - Cases with intravenous antibiotic + local antibiotic (Vancomycin, acts against gram positive bacteria) + local Gentamycin cement (acts against gram negative bacteria).
Procedure: Sampling will be based on stratified procedure. The total sample will be divided into categories based on the type of surgery, which are spine, trauma and joint replacement. Subjects within each category will be randomly selected for the three antibiotic treatments. For this study, we will use computer software to generate restricted randomization to achieve balance between groups in size. Within this restricted randomization, single block random size will be used to ensure randomization within each group.
While joint surgery category will have all the three groups of cases (a, b and c), spine and trauma surgery category will have only two groups (a and b). Surgeries will be performed accordingly i.e. control group individuals will undergo mandated hospital policy requirements + perioperative intravenous antibiotic treatment and cases will undergo mandated hospital policy requirements + powdered vancomycin, or both vancomycin, just before the closure of the wound, and gentamycin as a mix with bone cement. Patients who exhibit both superficial and deep wood infection will be considered as infected and accounted for statistical analysis.
Analysis: Our main parameter of comparison is infection percentage among control and cases. Various factors like duration of surgery, tourniquet time, prior infections, blood transfusion, haemoglobin count, comorbidities, etc, will be considered while analysing for infection percentage. Infection proportions will be compared between different groups at a significance level of 0.05.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Infection
Keywords
Vancomycin, Gentamycin, Local Powder Antibiotic's Efficacy in Controlling Post Surgical Infection
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
1844 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Vancomycin
Arm Type
Active Comparator
Arm Title
Vancomycin and Gentamycin
Arm Type
Active Comparator
Arm Title
Intravenous Antibiotic
Arm Type
Active Comparator
Intervention Type
Biological
Intervention Name(s)
Vancomycin
Intervention Description
1 pre-operative dose of intravenous Cefuroxime (1.5 gm) and 2 post-operative doses of Cefuroxime (750 mg) + 500 mg of vancomycin instilled on surgical site before closure
Intervention Type
Biological
Intervention Name(s)
Vancomycin and Gentamycin
Intervention Description
1 pre-operative dose of intravenous Cefuroxime (1.5 gm) and 2 post-operative doses of Cefuroxime (750 mg) and 500 mg of vancomycin powder on surgical site before closure with gentamycin bone cement for joint replacement cases.
Intervention Type
Biological
Intervention Name(s)
Cefuroxime
Intervention Description
1 pre-operative dose of Cefuroxime (1.5 gm) and 2 post-operative doses of Cefuroxime (750 mg)
Primary Outcome Measure Information:
Title
Infection percent after surgery
Time Frame
Within one year after surgery
10. Eligibility
Sex
All
Minimum Age & Unit of Time
10 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
All joint replacement patients
All non infected spine patients
Hemiarthroplasty, All upper limb plating of closed fractures
Exclusion Criteria:
Open injuries in trauma
Revision joint replacement surgeries
Patients with suspicion of existing infection
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rajasekaran Shanmuganathan, Ph.D.
Organizational Affiliation
Ganga Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Ganga Hospital, Orthopaedics Department
City
Coimbatore
State/Province
Tamil Nadu
ZIP/Postal Code
641043
Country
India
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Janardhan Yerramshetty, Ph.D.
Phone
0422-2485000
Email
jyerram@gmail.com
First Name & Middle Initial & Last Name & Degree
Rajasekaran Shanmuganathan, Ph.D.
12. IPD Sharing Statement
Learn more about this trial
Efficacy of Local Powder Prophylactics
We'll reach out to this number within 24 hrs